tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alan John Taylor Ceases to be Substantial Holder in Clarity Pharmaceuticals

Story Highlights
Alan John Taylor Ceases to be Substantial Holder in Clarity Pharmaceuticals

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has issued an announcement.

Clarity Pharmaceuticals Limited has announced that Alan John Taylor has ceased to be a substantial holder in the company as of August 1, 2025. This change is due to a dilution of shares following a recent placement announced on July 28, 2025, which affected the voting securities held by Taylor and associated entities. The impact of this announcement indicates a shift in shareholder dynamics, potentially influencing the company’s governance and stakeholder interests.

The most recent analyst rating on (AU:CU6) stock is a Buy with a A$8.20 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.

More about Clarity Pharmaceuticals Ltd.

Average Trading Volume: 3,098,329

Technical Sentiment Signal: Buy

Current Market Cap: A$1.4B

For detailed information about CU6 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1